Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease

This study is currently recruiting participants.
Verified May 2012 by Nycomed: A Takeda Company
Sponsor:
Information provided by (Responsible Party):
Nycomed: A Takeda Company
ClinicalTrials.gov Identifier:
NCT01509677
First received: December 21, 2011
Last updated: May 4, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)